STOUGHTON, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that it will report third quarter 2022 financial results after the market closes on Thursday, November 3, 2022. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q3 2022 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Contact:
Dawn Schottlandt
Argot Partners
collegium@argotpartners.com
VIENNA, Va., Dec. 18, 2025 /PRNewswire/ -- Attune announced today that the company will play…
VIENNA, Va., Dec. 18, 2025 /PRNewswire/ -- Attune announced today that the company will play…
New platform integrates wireless connectivity, communications and navigation to help enhance users' control over activities…
LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced…
New platform integrates wireless connectivity, communications and navigation to help enhance users' control over activities…
LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced…